13F filer · CIK 1977548
Checkpoint Capital L.P.
SAN FRANCISCO, CA · filing since Q4 2023 · last filing Aug 14, 2026
Reported value
$389.8M
+$111.1M vs prior
Positions
6
New / sold out
0 / 2
Added / reduced
3 / 3
Turnover
9.6%
buys $53.3M · sells $32.0M
Top-10 weight
100.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | REVOLUTION MEDICINES INC | +147,814 | +56.3% | +$27.7M |
| Added | CYTOKINETICS INC | +295,000 | +163.9% | +$25.1M |
| Added | TREVI THERAPEUTICS INC | +25,000 | +50.0% | +$466.2K |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | ARGENX SE | -21,717 | -14.2% | $-20.1M |
| Reduced | RHYTHM PHARMACEUTICALS INC | -41,200 | -3.4% | $-4.6M |
| Reduced | DISC MEDICINE INC | -46,536 | -16.2% | $-3.4M |
| Sold out | SEPTERNA INC | -100,300 | -100.0% | $-2.4M |
| Sold out | CRINETICS PHARMACEUTICALS IN | -40,230 | -100.0% | $-1.5M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | RHYTHM PHARMACEUTICALS INCCOM | 1,186,000 | $131.7M | 33.79% |
| 2 | ARGENX SESPONSORED ADR | 131,283 | $121.8M | 31.25% |
| 3 | REVOLUTION MEDICINES INCCOM | 410,353 | $76.9M | 19.72% |
| 4 | CYTOKINETICS INCCOM NEW | 475,000 | $40.5M | 10.38% |
| 5 | DISC MEDICINE INCCOM | 240,125 | $17.6M | 4.51% |
| 6 | TREVI THERAPEUTICS INCCOM | 75,000 | $1.4M | 0.36% |